Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis: results of a double-blind controlled multicentric trial
- 30 April 2000
- journal article
- clinical trial
- Published by Elsevier BV in Journal of Hepatology
- Vol. 32 (4), 561-566
- https://doi.org/10.1016/s0168-8278(00)80216-0
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosisGastroenterology, 1996
- Effects of ursodeoxycholic acid after 4 to 12 years of therapy in early and late stages of primary biliary cirrhosisJournal of Hepatology, 1994
- The canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosisJournal of Hepatology, 1994
- Different response to ursodeoxycholic acid (UDCA) in primary biliary cirrhosis according to severity of diseaseDigestive Diseases and Sciences, 1994
- Ursodeoxycholic acid for symptomatic primary biliary cirrhosis: Preliminary analysis of a double-blind multicenter trialJournal of Hepatology, 1993
- Ursodeoxycholic acid–induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosisJournal of Hepatology, 1990
- Ursodeoxycholic acid in primary biliary cirrhosis: no evidence for toxicity in the stages I to IIIJournal of Hepatology, 1990
- IS URSODEOXYCHOLIC ACID AN EFFECTIVE TREATMENT FOR PRIMARY BILIARY CIRRHOSIS?The Lancet, 1987
- The Prognostic Importance of Clinical and Histologic Features in Asymptomatic and Symptomatic Primary Biliary CirrhosisThe New England Journal of Medicine, 1983
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958